Industrial Materials
Compare Stocks
2 / 10Stock Comparison
CRMLW vs UAMY
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial Materials
CRMLW vs UAMY — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Industrial Materials | Industrial Materials |
| Market Cap | $437M | $1.54B |
| Revenue (TTM) | — | $39M |
| Net Income (TTM) | $-147M | $-4M |
| Gross Margin | — | 25.2% |
| Operating Margin | — | -21.5% |
| Forward P/E | — | 200.4x |
| Total Debt | $19M | $185K |
| Cash & Equiv. | $1M | $30M |
CRMLW vs UAMY — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 24 | May 26 | Return |
|---|---|---|---|
| Critical Metals Cor… (CRMLW) | 100 | 5454.5 | +5354.5% |
| United States Antim… (UAMY) | 100 | 5190.8 | +5090.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CRMLW vs UAMY
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CRMLW is the clearest fit if your priority is long-term compounding.
- 42.3% 10Y total return vs UAMY's 37.0%
- +23.5% vs UAMY's +190.8%
UAMY carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 1.88
- Rev growth 162.8%, EPS growth -150.0%, 3Y rev CAGR 52.6%
- Lower volatility, beta 1.88, Low D/E 0.1%, current ratio 5.38x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Quality / Margins | -11.1% margin vs CRMLW's -61.8% | |
| Stability / Safety | Beta 1.88 vs CRMLW's 2.96 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +23.5% vs UAMY's +190.8% | |
| Efficiency (ROA) | -5.4% ROA vs CRMLW's -312.7%, ROIC -10.3% vs -14.6% |
CRMLW vs UAMY — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CRMLW vs UAMY — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Insufficient data to determine a leader in this category.
Income & Cash Flow (Last 12 Months)
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | — | $39M |
| EBITDAEarnings before interest/tax | — | -$7M |
| Net IncomeAfter-tax profit | — | -$4M |
| Free Cash FlowCash after capex | — | -$37M |
| Gross MarginGross profit ÷ Revenue | — | +25.2% |
| Operating MarginEBIT ÷ Revenue | — | -21.5% |
| Net MarginNet income ÷ Revenue | — | -11.1% |
| FCF MarginFCF ÷ Revenue | — | -95.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +89.6% |
| EPS Growth (YoY)Latest quarter vs prior year | — | — |
Valuation Metrics
UAMY leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $437M | $1.5B |
| Enterprise ValueMkt cap + debt − cash | $455M | $1.5B |
| Trailing P/EPrice ÷ TTM EPS | -2.97x | -275.50x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 200.36x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | — | 39.31x |
| Price / BookPrice ÷ Book value/share | — | 9.67x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
UAMY leads this category, winning 7 of 7 comparable metrics.
Profitability & Efficiency
UAMY delivers a -6.1% return on equity — every $100 of shareholder capital generates $-6 in annual profit, vs $-23 for CRMLW. On the Piotroski fundamental quality scale (0–9), UAMY scores 4/9 vs CRMLW's 1/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -23.3% | -6.1% |
| ROA (TTM)Return on assets | -3.1% | -5.4% |
| ROICReturn on invested capital | -14.6% | -10.3% |
| ROCEReturn on capital employed | -21.7% | -9.7% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 4 |
| Debt / EquityFinancial leverage | — | 0.00x |
| Net DebtTotal debt minus cash | $18M | -$30M |
| Cash & Equiv.Liquid assets | $1M | $30M |
| Total DebtShort + long-term debt | $19M | $185,048 |
| Interest CoverageEBIT ÷ Interest expense | -0.08x | — |
Total Returns (Dividends Reinvested)
CRMLW leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CRMLW five years ago would be worth $432,693 today (with dividends reinvested), compared to $126,116 for UAMY. Over the past 12 months, CRMLW leads with a +2353.4% total return vs UAMY's +190.8%. The 3-year compound annual growth rate (CAGR) favors CRMLW at 2.5% vs UAMY's 2.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +97.8% | +85.8% |
| 1-Year ReturnPast 12 months | +2353.4% | +190.8% |
| 3-Year ReturnCumulative with dividends | +4226.9% | +3150.7% |
| 5-Year ReturnCumulative with dividends | +4226.9% | +1161.2% |
| 10-Year ReturnCumulative with dividends | +4226.9% | +3700.0% |
| CAGR (3Y)Annualised 3-year return | +2.5% | +2.2% |
Risk & Volatility
UAMY leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
UAMY is the less volatile stock with a 1.88 beta — it tends to amplify market swings less than CRMLW's 2.96 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UAMY currently trades 55.9% from its 52-week high vs CRMLW's 26.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.96x | 1.88x |
| 52-Week HighHighest price in past year | $20.73 | $19.71 |
| 52-Week LowLowest price in past year | $0.17 | $1.94 |
| % of 52W HighCurrent price vs 52-week peak | +26.0% | +55.9% |
| RSI (14)Momentum oscillator 0–100 | 56.6 | 62.5 |
| Avg Volume (50D)Average daily shares traded | 47K | 12.4M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $13.50 |
| # AnalystsCovering analysts | — | 4 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
UAMY leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). CRMLW leads in 1 (Total Returns).
CRMLW vs UAMY: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is CRMLW or UAMY a better buy right now?
Analysts rate United States Antimony Corporation (UAMY) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison.
The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CRMLW or UAMY?
Over the past 5 years, Critical Metals Corp.
(CRMLW) delivered a total return of +42. 3%, compared to +1161% for United States Antimony Corporation (UAMY). Over 10 years, the gap is even starker: CRMLW returned +42. 3% versus UAMY's +37. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CRMLW or UAMY?
By beta (market sensitivity over 5 years), United States Antimony Corporation (UAMY) is the lower-risk stock at 1.
88β versus Critical Metals Corp. 's 2. 96β — meaning CRMLW is approximately 57% more volatile than UAMY relative to the S&P 500.
04Which is growing faster — CRMLW or UAMY?
On earnings-per-share growth, the picture is similar: United States Antimony Corporation grew EPS -150.
0% year-over-year, compared to -154. 6% for Critical Metals Corp.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CRMLW or UAMY?
Critical Metals Corp.
(CRMLW) is the more profitable company, earning 0. 0% net margin versus -11. 1% for United States Antimony Corporation — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CRMLW leads at 0. 0% versus -21. 5% for UAMY. At the gross margin level — before operating expenses — UAMY leads at 25. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — CRMLW or UAMY?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is CRMLW or UAMY better for a retirement portfolio?
For long-horizon retirement investors, United States Antimony Corporation (UAMY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding.
Critical Metals Corp. (CRMLW) carries a higher beta of 2. 96 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UAMY: +37. 0%, CRMLW: +42. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between CRMLW and UAMY?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CRMLW is a small-cap quality compounder stock; UAMY is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.